Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

ºÒ¸í¿­·Î ¹ßÇöÇÑ ¸»ÃÊ T-¼¼Æ÷ ¸²ÇÁÁ¾ÀÇ ÀÓ»ó»ó Peripheral T-cell Lymphomas Presenting as Fever of Unknown Origin

´ëÇѾÏÇÐȸÁö 1998³â 30±Ç 2È£ p.329 ~ 337
¼Ò¼Ó »ó¼¼Á¤º¸
Çã´ë¼®/Dae Seog Heo À̱ټ®/ÇãÁÖ·É/¹æ¿µÁÖ/¹Ú¼±¾ç/±èö¿ì/±èº´±¹/±è³ë°æ/Keun Seok Lee/Joo Ryung Huh/Yung-Jue Bang/Seon Yang Park/Chul-Woo Kim/Byoung Kook Kim/Noe Kyeong Kim

Abstract

°á·Ð
ºÒ¸í¿­ ¹ßÇö±ºÀº ºñºÒ¸í¿­ ¹ßÇö±º¿¡ ºñÇØ Áø´Ü ´ç½Ã ÁøÇàµÈ º´±â¿¡ Àü½Å Áõ»óÀ» Àß µ¿¹Ý
ÇÏ¿´À¸¸ç, ½Åü È°µ¿´É·Âµµ ³·¾Ò´Ù. ºñºÒ¸í¿­ ¹ßÇö±ºÀÌ ºñ°­ ¹× ºÎºñµ¿À» Àß Ä§¹üÇϴµ¥ ºñ
ÇÏ¿©, ºÒ¸í¿­ ¹ßÇö±ºÀº ÇǺÎ, À§Àå°ü, °£ÀÇ Ä§¹üÀÌ ¸¹Àº ¼Ò°ßÀ» º¸¿´´Ù. ¶ÇÇÑ ºÒ¸í¿­ ¹ßÇö±º
Àº Áø´ÜÀÌ ºñºÒ¸í¿­ ¹ßÇö±º¿¡ ºñÇØ ¾î·Á¿ü´Ù. »ýÁ¸ ºÐ¼® »ó 2³â »ýÁ¸À²ÀÌ ºÒ¸í¿­ ¹ßÇö±ºÀº
26%,ºñºÒ¸í¿­ ¹ßÇö±ºÀº 67%¿´À¸¸ç, ºÒ¸í¿­ ¹ßÇö±ºÀº 3°³¿ù À̳»¿¡ 74%°¡ »ç¸ÁÇÏ´Â µî ¾ç
±º°£¿¡ À¯ÀÇÇÑ Â÷À̸¦ º¼ ¼ö ÀÖ¾ú´Ù(p<0.0001). ¿¹ÈÄ ÀÎÀÚ ºÐ¼®À» À§ÇÑ ´Ùº¯¼ö ºÐ¼®¿¡¼­µµ
ºÒ¸í¿­ ¹ßÇöÀº È°µ¿µµ, º´±â¿Í ÇÔ²² Åë°èÀûÀ¸·Î ÀÇ¹Ì ÀÖ´Â ¿¹ÈÄ ÀÎÀÚ·Î ¹àÇôÁ³´Ù. µû¶ó¼­ ºÒ
¸í¿­·Î ¹ßÇöÇÑ ¸»ÃÊ T-¼¼Æ÷ ¸²ÇÁÁ¾Àº ´Ù¾çÇÑ ¸»ÃÊ T-¼¼Æ÷ ¸²ÇÁÁ¾ ÁßÀÇ ÇÑ ºÐ·ù·Î °£ÁÖÇÒ
¼ö ÀÖÀ» °ÍÀ¸·Î »ç·áµÇ¸ç, ºÒ¸í¿­ ¹ßÇö ¸»ÃÊ T-¼¼Æ÷ ¸²ÇÁÁ¾À» Ư¡ Áö¿ì´Â »ý¹°ÇÐÀû ÀÎÀÚ
¸¦ ã´Â ¿¬±¸°¡ ÇÊ¿äÇÒ °ÍÀÌ´Ù.

Purpose : Peripheral T-cell lymphomas(PTCL) show diverse clinical and histological
characteristics and should be understood as mixtures of heterogeneous entities. Although
many clinical and biological parameters have been proposed for classifying PTCL into
different prognostic groups, few parameters have turned out to be appropriate for
classification. To investigate the clinical significance of FUO presentation in PTCL,
comparisons of clinical parameters were performed using non-FUO presentation as a
control.
Materials and Methods : 66 cases of Korean PTCL were divided into FUO group and
non-FUO group according to the presentation and compared with each other.
Results : Among 66 patients of PTCL, 19 patients presented with FUO. Compared
with non-FUO group, FUO group showed no significant age and sex ratio differences.
FUO group showed more advanced stage, worse performance status than non-FUO
group. Predominant sites of definite diagnosis were akin, gastrointestinal tract and liver
in FUO group and nasal cavity and paranasal sinus in non-FUO group. There were no
significant differences between histologic classifications of both groups. Survival analysis
revealed significant differences between both groups. FUO group showed significantly
shorter survival. Prognostic factor analysis(multivariate) was done with stage, LDH
level, performance status, and FUO status. FUO status, stage and performance status
were significant determinants of survival, but LDH level proved to have no prognostic
implication.
Conclusion : PTCL with FUO presentation showed such distinct characteristics that
the authors propose fever of unknown origin(FUO) as a clinical parameter for classifying
PTCL. Further studies are needed to identify biological parameters which characterize
PTCL with FUO presentation.

Å°¿öµå

Lymphoma; 7-cell; Peripheral; Fever of unknown origin; Prognosis;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KoreaMed
KAMS